- Foreigners to get citizenship after states' nod: Govt on Citizenship Bill
- EC seeks FIR against 'expert' who claimed EVMs were hacked in 2014 polls
- Renault board will meet Thursday to replace Ghosn; Bollore may be next CEO
- China cuts down army troops by about 50%; increases size of navy, air force
- Andhra CM Naidu proposes Kapu quota within Modi govt's 10% EWS quota
Are multinational pharma firms justified in pricing life savings drugs exhorbitantly?
MNCs claim they spend billions and billions of dollars on research and development to make life saving drugs and that they are forced to charge exhorbitantly high prices in order to stay in business. The flip side of this argument is that such drugs are out of reach for the poor and that profit should not be the sole motive for being in the business of wellness, and that cheaper variants of the drug should be made available to the poor by other companies that have the technology to make them. What is your view? Are the MNCs justified or are they just interested in profits, working as they are in an industry where the consumer -- the patient -- has little choice?